FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fusion Pharmaceuticals Dicopanol Recall

DICOPANOL (diphenhydramine hydrochloride in 5 mg/mL oral suspension kit) FusePaq, 150 m…

Fusion Pharmaceuticals, LLC · Camarillo, CA

Risk level
Class II
Reported by FDA
Mar 18, 2015
Recall ID
D-0410-2015
Check your lot numberHow we source this data

Summary

Fusion Pharmaceuticals recalled Dicopanol starting Mar 6, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0410-2015 on Mar 18, 2015. Reason: Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans. Status: Terminated.

Why it was recalled

Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.

Product description

DICOPANOL (diphenhydramine hydrochloride in 5 mg/mL oral suspension kit) FusePaq, 150 mL Kits, Rx Only. Fusion Pharmaceuticals LLC., 768 Calle Plano, Camarillo, CA 93012. NDC: 43093-104-01.

Lot numbers, UPCs & expiration codes

Lot Numbers: PL713, PL714, PL715, PL716, PL717, PL718, PL719, PL720, PL721, PL722, PL735, PL736, PL737, PL738, PL739, PL740, PL741, PL742, PL743, PL744; Expiry: 7/20/2015.

Where it was sold

California

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0410-2015
Classification
Class II
Status
Terminated
Recall initiated
Mar 6, 2015
FDA report date
Mar 18, 2015
Quantity
9,439 Kits
Recall type
Voluntary: Firm initiated
Recalling firm
Fusion Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0410-2015, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Terminated
Country
United States
Event ID
70682
Address
768 Calle Plano Suite A
Code information
Lot Numbers: PL713, PL714, PL715, PL716, PL717, PL718, PL719, PL720, PL721, PL722, PL735, PL736, PL737, PL738, PL739, PL740, PL741, PL742, PL743, PL744; Expiry: 7/20/2015.
Postal code
93012-8555
Report date
Mar 18, 2015
Product type
Drugs
Recall number
D-0410-2015
Classification
Class II
Recalling firm
Fusion Pharmaceuticals, LLC
Product quantity
9,439 Kits
Termination date
Oct 27, 2015
Reason for recall
Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.
Voluntary / mandated
Voluntary: Firm initiated
Product description
DICOPANOL (diphenhydramine hydrochloride in 5 mg/mL oral suspension kit) FusePaq, 150 mL Kits, Rx Only. Fusion Pharmaceuticals LLC., 768 Calle Plano, Camarillo, CA 93012. NDC: 43093-104-01.
Distribution pattern
California
Recall initiation date
Mar 6, 2015
Initial firm notification
Letter
Center classification date
Mar 12, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0410-2015, published Mar 18, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls